Skip to content

Exercise training and COVID-19: a randomized controlled trial

Exercise training and COVID-19: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160605028270N3
Enrollment
900
Registered
2021-09-01
Start date
2021-09-06
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19 disease

Interventions

Intervention 1: Non-exercise group: will not participate in any exercise training protocol. Intervention 2: Intervention group: aerobic exercise training. Subjects in this group will participate in mo

Sponsors

Allameh Tabataba’i University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 94 Years

Inclusion criteria

Inclusion criteria: laboratory-confirmed COVID-19 patients. Tendency and ability to participate in exercise protocols.

Exclusion criteria

Exclusion criteria: Physically active subjects. Participants with a history of using cigarettes and alcohol in the last 6 months.

Design outcomes

Primary

MeasureTime frame
Tissue biomarkers including blood, saliva, semen, and urine. Timepoint: Baseline, weeks 4, 8, 12, 16, and one month of detraining. Method of measurement: White blood cells, neutrophils, and lymphocytes in blood, saliva, seminal fluid, and urine will be measured according to the standard laboratory techniques.

Secondary

MeasureTime frame
Body composition. Timepoint: Baseline, weeks 4, 8, 12, 16 and 1 month of detraining. Method of measurement: By using Omron body composition analyzer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehzad Hajizadeh Maleki

Allameh Tabataba’i University

behzad.hajizadeh-maleki@sport.uni-giessen.de+98 21 4839 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 10, 2026